JPMorgan Chase & Co’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.09M | Sell |
914,743
-495,361
| -35% | -$1.13M | ﹤0.01% | 3314 |
|
2025
Q1 | $2.19M | Buy |
1,410,104
+338,571
| +32% | +$525K | ﹤0.01% | 3201 |
|
2024
Q4 | $2.52M | Sell |
1,071,533
-213,175
| -17% | -$501K | ﹤0.01% | 3249 |
|
2024
Q3 | $4.66M | Buy |
1,284,708
+761,008
| +145% | +$2.76M | ﹤0.01% | 2683 |
|
2024
Q2 | $1.82M | Buy |
523,700
+394,791
| +306% | +$1.37M | ﹤0.01% | 3167 |
|
2024
Q1 | $822K | Buy |
128,909
+101,476
| +370% | +$647K | ﹤0.01% | 3683 |
|
2023
Q4 | $177K | Buy |
27,433
+27,327
| +25,780% | +$176K | ﹤0.01% | 4508 |
|
2023
Q3 | $247 | Sell |
106
-1,693
| -94% | -$3.95K | ﹤0.01% | 5854 |
|
2023
Q2 | $4.28K | Sell |
1,799
-439,226
| -100% | -$1.05M | ﹤0.01% | 5302 |
|
2023
Q1 | $811K | Sell |
441,025
-52,484
| -11% | -$96.5K | ﹤0.01% | 3565 |
|
2022
Q4 | $938K | Buy |
493,509
+50,959
| +12% | +$96.9K | ﹤0.01% | 3390 |
|
2022
Q3 | $947K | Sell |
442,550
-183,969
| -29% | -$394K | ﹤0.01% | 3393 |
|
2022
Q2 | $1.77M | Sell |
626,519
-173,039
| -22% | -$490K | ﹤0.01% | 3094 |
|
2022
Q1 | $3.33M | Sell |
799,558
-51,986
| -6% | -$217K | ﹤0.01% | 2838 |
|
2021
Q4 | $4.42M | Sell |
851,544
-499,811
| -37% | -$2.59M | ﹤0.01% | 2669 |
|
2021
Q3 | $8.85M | Buy |
1,351,355
+600,391
| +80% | +$3.93M | ﹤0.01% | 2146 |
|
2021
Q2 | $4.99M | Buy |
750,964
+196,595
| +35% | +$1.31M | ﹤0.01% | 2642 |
|
2021
Q1 | $3.18M | Buy |
554,369
+300,109
| +118% | +$1.72M | ﹤0.01% | 2953 |
|
2020
Q4 | $2.27M | Buy |
254,260
+75,626
| +42% | +$676K | ﹤0.01% | 2888 |
|
2020
Q3 | $2.14M | Buy |
178,634
+37,879
| +27% | +$455K | ﹤0.01% | 2707 |
|
2020
Q2 | $2.26M | Buy |
140,755
+39,308
| +39% | +$630K | ﹤0.01% | 2621 |
|
2020
Q1 | $608K | Buy |
101,447
+63,234
| +165% | +$379K | ﹤0.01% | 3216 |
|
2019
Q4 | $504K | Buy |
+38,213
| New | +$504K | ﹤0.01% | 3418 |
|